Summary The activities and the expression of 3-methyladenine glycosylase (3-meAde gly) and O6-alkylguanine-DNA-alkyltransferase (06ATase) were investigated in ten human cancer cell lines. Both 3-meAde gly and 06ATase activities were variable among different cell lines. mRNA levels of the 06ATase gene, appeared to be related to the content of 06ATase in different cell lines, whereas no apparent correlation was found between mRNA of 3-meAde gly and the enzymatic activity. No correlation was found between the activity of the two enzymes and the sensitivity to alkylating agents of different structures such as CC-1065, tallimustine, dimethylsulphate (DMSO), N-methyl-N'-nitro-N-ntirosoguanidine (MNNG), cis-diamminedichloroplatinum (cDDP) and melphalan (L-PAM). The most striking finding of this study is that a correlation exists between the activity of O6ATase and 3-meAde gly in the various cell lines investigated (P<0.01), suggesting a common mechanism of regulation of two DNA repair enzymes.
Alkylating agents can cause a variety of DNA adducts, the alkylpurines being the main ones (Baranek, 1990; Margison and O'Connor, 1990) . These alkylations are eliminated in prokaryotes and eukaryotes (Olsson and Lindahl, 1980; Mehta et al., 1981; Lindahl, 1976; Laval, 1977) through an o6 alkylguanine alkyltransferase (O6ATase) acting on o6 methylguanine (06-meGua) and a 3-methyladenine glycosylase (3-meAde gly) acting on a 3-methyladenine (3-meAde) and other alkylpurines.
The molecular effect of alkylation of guanines at the o6 position is well defined, resulting in a mismatch and, after DNA replication, in a transition mutation (Loveless, 1969) . Such DNA lesions can cause lethal events through an abortive mismatch repair (Kat et al., 1993) . In this respect the role of O6ATase has been related to resistance to alkylating agents in various biological systems, from prokaryotes to mammals. Less is known about the 3-alkyladenine in DNA. While in Escherichia coli such alkylated bases represent a lethal event (Boiteux et al., 1984; Lindahl et al., 1988) , it is still to be confirmed whether it is lethal or mutagenic in mammalian cells. E. coli displays two glycosylase activities able to repair 3-alkyladenine, encoded by the tag and alkA gene products (Bjelland et al., 1993; Nakabeppu et al., 1994) .
Mammalian cells seem to have only one type of adenine glycosylase, more like the alkA than the tag gene product. Recently the mouse, rat and human 3-meAde gly cDNA have been cloned (Engelward et al., 1993; O'Connor and Laval, 1990; Samson et al., 1991; Chakravarti et al., 1991) .
The enzyme's precise role in protecting cells from the cytotoxic effects of alkylating agents is still controversial (Klungland et al., 1992; Habraken and Laval, 1993; Imperatori et al., 1994; Ibeanu et al., 1992; Matijasevic et al., 1993 ). Klungland et al. (1992 reported that V79 hamster lung fibroblasts and murine haematopoietic cells permanently expressing the tag gene showed increased resistance to killing by methylmethanesulphonate (MMS) and methylnitrosurea (MNU). Habraken and Laval (1993) demonstrated that the expression of the alkA or mammalian glycosylase in irsl cells rendered them resistant to the toxic effects of both MMS and ethylmethanesulphonate (EMS). However, Imperatori et al. (1994) and Ibenau et al. (1992) , who respectively transfected the tag and the mammalian glycosylase gene in different cell lines, could not find any increased resistance to the toxic effects of alkylating agents in the stable transfectants, in spite of the high level of glycosylase expression. It was suggested that the level of the endogenous enzyme might account for these differences. Further studies are needed to establish the enzyme's role in the repair of the lesions induced by alkylating agents and in determining tumour resistance to the alkylating agents used in cancer chemotherapy. The lack of data on the enzymatic activity of 3-meAde gly in human tumour cells prompted us to conduct a study in which the enzymatic activity was determined in a number of cancer cell lines together with O6ATase level and sensitivity to alkylating agents.
The alkylating agents selected were CC1065 and tallimustine, known to alkylate N3 adenine in a DNA sequence specific manner; N -methyl -NY -nitro -N -nitrosoguanidine (MNNG) and dimethylsulphate (DMS) for their ability to cause a broader alkylation pattern; and two cross-linking agents, cis-diamminedichloroplatinum (cDDP) and melphalan (L-PAM).
Materials and methods

Cell culture
The ovarian carcinoma cell lines IGROV, SW626, OV-CAR3.S, SKOV-3, the human leukaemia cell lines CEM, U937, K562 and Jurkat were maintained in RPMI-1640 (Gibco Europe, Glasgow, UK); human colon carcinoma cell lines HT-29 and LoVo were maintained respectively in Eagle's minimum essential medium (MEM) (Gibco) and F-12 (Biological Industries) media. All cell lines were supplemented with 10% fetal calf serum (Biological Industries, Kibbutz Beth Haemek, Israel) Figure 2 shows the Northern blot analysis of RNA extracted from the different cell lines. 3-meAde gly transcript was detected in all cells except OVCAR3.S, but the RNA expression did not seem to be quantitatively correlated with the enzymatic activity (Table I and Figure 2 ). For example, the Jurkat cell line showed quite a high level of enzymatic activity (1.41 fmol pg-' DNA min-1) but very low mRNA expression (Figure 2, lane 3) (Pendlebury et al., 1994) . The functional role, if any, of these two isoforms has yet to be established. They might display different substrate specificity, even if there are no data yet to confirm this hypothesis. The probe we used for the 3-meAde gly mRNA detection is homologous for both these isoforms, so that the discrepancy between the mRNA expression and the enzymatic activity, based on the ability to remove labelled-3-meAde from DNA, could also be explained by the different substrate specificity of the two isoforms. Interestingly, we found a significant correlation (P <0.01) between the levels of enzymatic activity. To our knowledge no data have been published so far on the expression and activity of these two DNA repair enzymes in the same human cell lines. In E. Coli, both enzymes exist as constitutive (respectively the tag and otg gene products) (Sakumi et al., 1986; Bjelland and Seeberg, 1987; Pegg and Byers, 1992) or inducible forms (respectively the AlkA and ada gene products) (Nakabeppu et al., 1984; Karran et al., 1982; Evensen and Seeberg, 1982) . This induction, which is termed the adaptive response, is an efficient system that enables E. Coli to respond to damage by alkylating agents. In Saccaromyces cerevisiae the alkylation damage is repaired by a methyltransferase (encoded by MTGI) and 3-meAde gly (encoded by MAG) that releases O6meGua, 3meAde and 7meAde from alkylated DNA (Chen et al., 1990; Xiao and Samson, 1992) . MAG but not MTGJ is inducible by DNA damage (Chen and Samson, 1991; Xiao et al., 1991) . A decamer consensus sequence has been recently identified in the promoters of the MAG, MGTI and several other genes involved in the DNA repair and metabolism (Xiao et al., 1993) , suggesting a common mechanism of regulation. In mammalian cells induction of alkyltransferase activity has been shown in some cases, but the changes are much more modest than the ones seen in E. Coli, up to 10-fold. Induction of O6ATase has been reported in human cancer cells after challenge with alkylating agents, but this finding has not always been confirmed (Pegg, 1990; Laval, , 1991 . The mechanisms underlying these increases have not been studied in detail, but they are probably at the level of transcription (Laval, 1991) .
Our finding that the contents of these two DNA repair proteins, which are involved in the repair of alkylated DNA, are correlated suggests a common mechanism of regulation, and studies are currently underway in our laboratory to clarify this.
We found no correlation between the level of 3-meAde gly and the sensitivity to different alkylating agents, methylating agents or other alkylators with different structure and different interactions with DNA. In the case of tallimustine and CC-1065, two minor groove binders known to alkylate N3 adenine in a sequence-specific manner (Broggini et al., 1994) , the explanation could be that the kind of adduct formed on N3 adenine is bulky and might not be recognised and cleaved by the enzyme. For the cross-linking agents L-PAM and cDDP too, the cytotoxic lesions appear to be the cross-links between two adjacent guanines or guanines located on opposite strands, so the alkylation of N3 adenine might be relatively unimportant for their cytotoxicity. In fact it has been shown that the nucleotide excision repair plays an important role in the repair of the lesions caused by cDDP and L-PAM treatment (Lee et al., 1993; Larminat and Bohr, 1994) .
For methylating agents (DMS and MNNG) the lack of correlation between the levels of the DNA repair protein and the sensitivity confirmed previous findings (Imperatori et al., 1994) on murine cells expressing the E. Coli tag or human MPG gene, which did not become resistant to the toxic effects of methylating agents. As already proposed, the endogenous levels of 3-meAde gly might be the crucial factor governing the sensitivity to methylating treatment. In the ten lines selected for this study, the 3-meAde gly contents were relatively high, possibly sufficient per se to repair the 3-meAde adduct caused by treatment with alkylating agents. In fact, resistance to methylating treatment has been reported in cell lines transfected with the tag gene, with an increase in the level of repair activity from 0.6 to 4.3 fmol mg-' protein min-1 (O'Connor and .
The other major factor for resistance to methylating agents is the cellular content of O6ATase. However, no correlation between the transferase activity and cellular sensitivity to different alkylating agents, particularly with MNNG and DMS, which are known to cause the highest proportion of O6meGua was found. It has already been shown that the sensitivity to MNNG is not necessarily associated with O6ATase level (Lefebvre and Laval, 1993) . Recently a defective mismatch repair has also been implicated in resistance and tolerance to some alkylating agents (such as MNU and MNNG). In this case 06-meGua persists in tolerant cells but is no longer lethal. The current underlying hypothesis is that methylation tolerance arises through the loss of a mismatch repair system that is defective in many tolerant cells (Karran and Bignami, 1994) .
In conclusion, the present findings suggest that the two repair enzymes, 3meAde gly and O6ATase, are not necessarily vital to the sensitivity to various alkylating agents. It is likely that after DNA damage a cascade of events occurs, resulting in a certain degree of survival. For example, two cell lines may have the same level of DNA damage and the same rate of adduct removal but the activation of different pathways for cell survival, for example activation of different proteins involved in cell growth and survival (e.g. p53), so that no single factor is likely to be responsible for the sensitivity or resistance to a certain drug.
